Subscribe to Biopharmaceutical

The Lead

Discovery Could Lead to Homemade Morphine, Painkillers

May 19, 2015 11:01 am | by Alicia Chang, AP Science Writer | News | Comments

Scientists have figured out all the steps to make morphine and similar painkillers without using opium poppies, potentially opening the door for home-brewed drugs. Some experts are calling for regulations to prevent tinkerers from making morphine, which can be converted into heroin.

10-lb. Packages of Marijuana Wash Ashore in 2 States

May 15, 2015 11:35 am | by The Associated Press | News | Comments

Beach dwellers in Alabama and North Carolina have stumbled upon bulky packages worth thousands...

Eli Lilly, Sanford-Burnham Announce Collaboration

May 14, 2015 12:00 pm | by Eli Lilly and Company | News | Comments

Eli Lilly and Company and Sanford-Burnham Medical Research Institute today announced that they...

Colombian Ban on Anti-Coca Herbicide is Bittersweet

May 14, 2015 11:54 am | by Jacobo Garcia, Associated Press | News | Comments

Colombian President Santos last week decided to halt fumigation in the wake of a report by a...

View Sample

FREE Email Newsletter

Personalized Medicine Gaining Traction, Facing Challenges

May 14, 2015 11:48 am | by Tufts Center for the Study of Drug Development | News | Comments

Thirteen percent of drugs marketed in the United States today post pharmacogenomic information on the label, but developers continue to encounter compliance challenges.

TRACON Q1 Results

May 14, 2015 11:29 am | by TRACON Pharmaceuticals | News | Comments

TRACON Pharmaceuticals, a clinical stage biopharmaceutical company, today announced its financial results for the first quarter.

ProPharma Group Acquires PROSAR

May 14, 2015 11:21 am | by ProPharma Group | News | Comments

ProPharma Group, a  compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.


SAFC Expands in St. Louis

May 13, 2015 11:43 am | by Sigma-Aldrich Corporation | News | Comments

Sigma-Aldrich Corporation has completed the expansion of its St. Louis facility to support commercial-scale antibody drug conjugate (ADC) manufacturing.

Pennsylvania Senate Passes Medical Marijuana Bill

May 13, 2015 11:36 am | by Marc Levy, Associated Press | News | Comments

State senators, for a second time, have sent legislation legalizing medical marijuana to the House of Representatives, where the GOP majority has held hearings but given no certain signs of support.

ANI Acquires Rights to Testosterone Gel 1%

May 13, 2015 11:31 am | by ANI Pharmaceuticals | News | Comments

ANI Pharmaceuticals has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals.

Vitae Pharmaceuticals Q1 Results

May 13, 2015 11:19 am | by Vitae Pharmaceuticals | News | Comments

Vitae Pharmaceuticals, a clinical-stage biotechnology company, recently provided financial results and pipeline reports for the first quarter of 2015.

Pfizer Acquires Minority Interest in AM-Pharma

May 12, 2015 11:41 am | by Pfizer | News | Comments

Pfizer recently announced their acquisition of a minority equity interest in AM-Pharma, and secured an exclusive option to acquire the remaining equity in the company.


SAFC Expands Gene Therapy Facility

May 12, 2015 11:37 am | by Sigma-Aldrich Corporation | News | Comments

Sigma-Aldrich Corporation's new facility will support commercial-scale gene therapy production, testing and filling.

Juno Acquires Stage Cell

May 12, 2015 11:15 am | by Juno Therapeutics | News | Comments

Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that it has acquired Stage Cell Therapeutics GmbH.

Inovio Unveils Clinical Trial for Ebola Immunotherapy

May 12, 2015 11:06 am | by Inovio Pharmaceuticals | News | Comments

Inovio Pharmaceuticals announced that the company has initiated a phase I trial to evaluate the safety, tolerability and immune responses of their DNA immunotherapy for Ebola.

2 Dead, 29 Sickened From Bad Vaccines

May 11, 2015 11:00 am | by The Associated Press | News | Comments

Mexico's public health system has suspended infant vaccines and mounted an investigation after vaccinations for tuberculosis, rotovirus and Hepatitis B resulted in devestation for an impoverished southern community.

Liberia Cautiously Marks End of Ebola

May 11, 2015 10:55 am | by Jonathan Paye-Layleh and Krista Larson, Associated Press | News | Comments

Saturday marked 42 days since Liberia's last Ebola case — the benchmark used to declare the outbreak over. The epidemic claimed more than 4,700 lives in the country.


Rexahn Pharmaceuticals Updates Pipeline

May 11, 2015 10:34 am | by Rexahn Pharmaceuticals | News | Comments

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing therapeutics for the treatment of cancer provided an update of its three clinical development programs.

FDA Fast Tracks Sucampo's Cobiprostone

May 11, 2015 10:28 am | by Sucampo Pharmaceuticals | News | Comments

The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator for the prevention of oral mucositis.

Bellicum Leases Space for Pilot Manufacturing Facility

May 8, 2015 11:43 am | by Bellicum Pharmaceuticals | News | Comments

Bellicum Pharmaceuticals, Inc. today announced that it has entered into a lease agreement to enable in-house cell therapy manufacturing to supply clinical trials.

Ebola is Found in Doctor's Eye Months After Virus Left Blood

May 8, 2015 11:33 am | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

For the first time, Ebola has been discovered inside the eyes of a patient months after the virus was gone from his blood.

Synthetic Pot Leads to Nationwide Spike in Hospitalizations

May 8, 2015 11:29 am | by Dave Collins, Associated Press | News | Comments

A huge nationwide spike in hospitalizations last month was caused by a class of drugs often called synthetic marijuana, possibly illustrating the potency and dangers of the chemicals used to make them.

Pharmaceuticals, Life Sciences Show Dramatic Jump in Merger Activity

May 8, 2015 11:15 am | by Andy Szal, Digital Reporter | News | Comments

The pharmaceuticals and life sciences sectors saw 35 mergers and acquisitions worth $166.3 billion in the first three months of 2015, a value that eclipsed transactions from all of 2014.

Using a Smartphone Microscope to Detect Parasites in Blood

May 7, 2015 11:43 am | by Lauran Neergaard, AP Medical Writer | News | Comments

Prick a finger and have the blood checked for parasites — by smartphone?


May 7, 2015 11:30 am | by ZIOPHARM Oncology | News | Comments

Dr. Cooper brings extensive experience in pioneering the development of adoptive cellular therapies in the field of oncology and translating immunology into clinical practice.

MorphoSys Acquires Lanthio Pharma

May 7, 2015 11:16 am | by MorphoSys AG | News | Comments

MorphoSys AG announced today that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V.

Eli Lilly to Build Drug Delivery Innovation Center

May 6, 2015 11:20 am | by Eli Lilly | News | Comments

Eli Lilly and Company today announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts.

Alexion Pharma to Pay $8.4 Billion for Synageva BioPharma

May 6, 2015 11:14 am | by Tom Murphy, AP Business Writer | News | Comments

Alexion Pharmaceuticals will pay a huge premium to buy fellow rare disease treatment maker Synageva BioPharma in an $8.4-billion deal for a company with no products on the market.

PlasmaTech Acquires Abeona

May 6, 2015 11:08 am | News | Comments

PlasmaTech Biopharmaceuticals has acquired Abeona Therapeutics, a company engaged in the development and commercialization of therapies for patients with lysosomal storage diseases.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.